Financial Appendix. Terms describing calculations and reporting of Operating Profits (Losses) are set forth in the Financial Appendix. The Financial Appendix is applicable to revenues and expenses by a Party in the United States. For revenues and expenses by a Sublicensee, the definitions may need to be modified to comply with changes to GAAP or to comply with ex-U.S. financial accounting standards. Any such modification, however, will be consistent with the agreed Cost Sharing Ratio and with the material concepts in the existing Financial Appendix.
Financial Appendix. Student’s first and last names: Class: ACCOMMODATION The host company or organisation will cover accommodation expenses: YES - NO Actuals or fixed rate amount: MEALS The host company or organisation will cover the cost of meals: YES - NO Actuals or fixed rate amount: TRANSPORT (Please tick) The student’ will travel by: bus train car other means of transport The school will cover transport expenses: YES – NO Actual or fixed rate amount: The host company or organisation will cover transport expenses: YES – NO Actual or fixed rate amount: INSURANCE: - School (for the student’s vocational activities in the workplace) - Student’s family (for the student’s activities that are not linked to the time spent in the professional environment) SIGNATURES Drawn up on (date) Head of the host company or organisation (signature and official stamp, when possible) Drawn up on (date) Head of the school Read and understood on (date) Legal representative for the student under the age of 18 Read and understood on (date)
Financial Appendix. This Exhibit E sets forth the principles for capturing, reporting and consolidating Development Costs, Commercialization Costs, and Profit sharing. Roche shall be responsible for all other costs with respect to Licensed Product(s). For such purpose, this Exhibit E sets forth the principles for reporting actual results and budgeted plans in the United States, the frequency of reporting, the use of a single “Functional Currency” (as defined under the heading “Foreign Exchange” below) and the methods of determining payments to the Parties, auditing of accounts and other matters.
Financial Appendix. For purposes of this Exhibit only, the consolidated accounting of operations for the collaboration in the Shared Territory shall be referred to as the “Collaboration”. The Collaboration is not a legal entity, or a partnership within the meaning of any tax laws, and has been defined for identification purposes only. This Financial Appendix addresses the financial planning, accounting policies and procedures to be followed in determining Profits and Losses, and related sharing of revenue and expenses, in the Shared Territory between Roche Nutley and Prothena US (for purposes of this Exhibit 1.35 only, the “Collaboration Parties”). Terms not defined in this Exhibit shall have the meanings set forth in Article 1 of the body of this Agreement. This Exhibit sets forth the principles for reporting actual results and budgeted plans of the combined operations by the Collaboration Parties in the Shared Territory, the frequency of reporting, the use of a single functional currency for reporting, and the methods of determining payments to the Collaboration Parties and auditing of accounts.
Financial Appendix. The agreed Milestone Payment Plans for phases C/D and support to phase E1 are indicative and will be finally consolidated prior to the start of phase C/D and phase E1 respectively
Financial Appendix. 5 1.47 Finished Product..............................................5 1.48 First Commercial Sale..........................................5 1.49 First Offer Termination Date...................................5 1.50 Fully Burdened Manufacturing Cost..............................5 1.51 GAAP...........................................................5 1.52
Financial Appendix. 2014/1* The hours per week and rotational staffing for the initial transitional period are listed below as a reference point. Within your pricing schedule we require the costs for the initial 3 weeks and the ongoing 2-1 support thereafter. Week 1 Staff member Week 2 Staff member Week 3 Staff member Mon 1 Mon 3 Mon 2 Tue 2 Tue 1 Tue 3 Wed 3 Wed 2 Wed 1 Thur 1 Thur 3 Thur 2 Fri 2 Fri 1 Fri 3 Week Number Anticipated Hours/Week Hourly Rate Projected Cost 1 30 2 30 3 30 4 onwards 60 It is felt that there will be a need to rota three staff to cater for the Service Users needs in the event that one person would be off sick other otherwise unavailable (see Staff members 1, 2 and 3 above).. Support should be delivered in accordance with the Support Plan, to an agreed rota (for example above) and meet the needs of the Service User described in the pen picture, Unified Assessment documents supplied through the Tender process and the Support Plan which will follow. From the fourth week of starting within the Service, there will need to be two Staff members to support the Service User needs, hence the increase from 30 hours to 60 hours per week. Please be advised that the hours above may increase or decrease in accordance with the revised needs of the Service User and the Council withholds the rights to change the baseline hours at any time in accordance with needs. Although there may be additional costs towards delivering the Service to the Service User, any additional costs will be proportioned between the Council, ABMUHB and Provider on an agreed basis and it is felt that the costs are anticipated to be minor in nature (e.g. support towards activities such as swimming etc.).” Signatories To The Agreement: On behalf of the Council Designation: Print Name: Signed: Date: On behalf of the Provider Designation: Print Name: Signed: Date:
Financial Appendix. In the event of an irreconcilable conflict between this Agreement and the Financial Appendix, the terms of the Financial Appendix shall prevail.
Financial Appendix. The term “
Financial Appendix. This Appendix (“Financial Appendix”) to the Collaboration, Option and License Agreement between F. Hoffmann-La Roche Ltd, with an office and place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (“Roche Basel”) and Hoffmann-La Roche Inc., with an office and place of business at 150 Clove Road, Suite 8, Little Falls, New Jersey 07424, U.S.A. (“Roche US”; Roche Basel and Roche US together referred to as “Roche”), on the one hand, and Vividion, Inc., with an office and place of business at 5820 Nancy Ridge Drive, San Diego, CA 92121, U.S.A. (“Vividion”), on the other hand, effective as of April 3, 2020 (the “Agreement”) addresses certain financial definitions and related principles of reporting and reconciliation to be followed in determining on a Vividion PoC Program-by-Vividion PoC Program basis with respect to each Vividion PoC Program and on a Shared Product-by-Shared-Shared Product basis (but not for any Compounds or Products, under Roche Programs, Optioned Roche Programs), and for the purposes of this Appendix and the Agreement only, the sharing of (a) costs pertaining to the Development of Compounds and Products under Vividion PoC Programs and/or Shared Products for the Territory, as applicable, and (b) Shared Profits and Losses for Shared Products in the US, each (a) and (b) as set forth in the Agreement and this Appendix 1. Terms not defined in this Financial Appendix shall have the meanings set forth in the body of the Agreement to which this Financial Appendix is attached. For each Vividion PoC Program or Shared Product and on a Vividion PoC Program-by-Vividion PoC Program or Shared Product-by-Shared Product basis, the following processes and definitions shall be utilized to calculate, and reimburse or share, as applicable, such Allowable Expense and Shared Profits and Losses (for Shared Products only) between the Parties.
